(Stroke. 2000;31:1945.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Division of Cardiothoracic Surgery, Department of Surgery (G.K.K., T.M.S.), and Department of Neurology and the Center for the Study of Nervous System Injury (C.Y.H.), Washington University School of Medicine; the Department of Anatomy and Neurobiology, St Louis University School of Medicine (X.M.X., X.L.); and the Department of Surgery, Missouri Baptist Hospital (N.T.K.), St Louis.
Correspondence to Dr Chung Y. Hsu, Department of Neurology, Washington University School of Medicine, St Louis, MO 63110. E-mail hsuc{at}neuro.wustl.edu
Background and PurposeSpinal cord ischemia is a serious complication of surgery of the aorta. NMDA receptor activation secondary to ischemia-induced release of glutamate is a major mechanism of neuronal death in gray matter. White matter injury after ischemia results in long-tract dysfunction and disability. The AMPA/kainate receptor mechanism has recently been implicated in white matter injury.
MethodsWe studied the effects of AMPA/kainate receptor blockade on ischemic white matter injury in a rat model of spinal cord ischemia.
ResultsIntrathecal administration of an AMPA/kainate antagonist, 6-nitro-7-sulfamoyl-(f)-quinoxaline-2,3-dione (NBQX), 1 hour before ischemia reduced locomotor deficit, based on the Basso-Beattie-Bresnahan scale (0=total paralysis; 21=normal) (sham: 21±0, n=3; saline: 3.7±4.5, n=7; NBQX: 12.7±7.0, n=7, P<0.05) 6 weeks after ischemia. Gray matter damage and neuronal loss in the ventral horn were evident after ischemia, but no difference was noted between the saline and NBQX groups. The extent of white matter injury was quantitatively assessed, based on axonal counts, and was significantly less in the NBQX as compared with the saline group in the ventral (sham: 1063±44/200x200 µm, n=3; saline: 556±104, n=7; NBQX: 883±103, n=7), ventrolateral (sham: 1060±135, n=3; saline: 411±66, n=7; NBQX: 676±122, n=7), and corticospinal tract (sham: 3391±219, n=3; saline: 318±23, n=7; NBQX: 588±103, n=7) in the white matter on day 42.
ConclusionsResults indicate severe white matter injury in the spinal cord after transient ischemia. NBQX, an AMPA/kainate receptor antagonist, reduced ischemia-induced white matter injury and improved locomotor function.
Neurosurgical Laboratories Stanford University Palo Alto, California
This article has been cited by other articles:
![]() |
T. Horiuchi, M. Kawaguchi, N. Kurita, S. Inoue, M. Nakamura, N. Konishi, and H. Furuya The Long-Term Effects of Mild to Moderate Hypothermia on Gray and White Matter Injury After Spinal Cord Ischemia in Rats Anesth. Analg., August 1, 2009; 109(2): 559 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sirlak, S. Eryilmaz, M. Bahadir Inan, Y. S. Sirin, O. Besalti, L. Yazicioglu, E. Ozcinar, E. Erdemli, R. Tasoz, A. H. Elhan, et al. Effects of carbamazepine on spinal cord ischemia. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1038 - 1043.e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. McCarran and M. P. Goldberg White Matter Axon Vulnerability to AMPA/Kainate Receptor-Mediated Ischemic Injury Is Developmentally Regulated J. Neurosci., April 11, 2007; 27(15): 4220 - 4229. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shi, X. Jiang, T. Kazui, N. Washiyama, K. Yamashita, H. Terada, and A. H. M. Bashar Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 942 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kurita, M. Kawaguchi, T. Horiuchi, S. Inoue, T. Sakamoto, M. Nakamura, N. Konishi, and H. Furuya An Evaluation of White Matter Injury After Spinal Cord Ischemia in Rats: A Comparison with Gray Matter Injury Anesth. Analg., March 1, 2005; 100(3): 847 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wosik, F. Ruffini, G. Almazan, A. Olivier, J. Nalbantoglu, and J. P. Antel Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury Brain, December 1, 2004; 127(12): 2636 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Sanchez-Gomez, E. Alberdi, G. Ibarretxe, I. Torre, and C. Matute Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors J. Neurosci., October 22, 2003; 23(29): 9519 - 9528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Goldberg and B. R. Ransom New Light on White Matter Stroke, February 1, 2003; 34(2): 330 - 332. [Full Text] [PDF] |
||||
![]() |
H. S. Maniar, T. M. Sundt III, S. M. Prasad, C. M. Chu, C. J. Camillo, M. R. Moon, B. G. Rubin, and G. A. Sicard Delayed paraplegia after thoracic and thoracoabdominal aneurysm repair: a continuing risk Ann. Thorac. Surg., January 1, 2003; 75(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Tekkok and M. P. Goldberg AMPA/Kainate Receptor Activation Mediates Hypoxic Oligodendrocyte Death and Axonal Injury in Cerebral White Matter J. Neurosci., June 15, 2001; 21(12): 4237 - 4248. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |